Baxter issues urgent recall of Heparin

Jan 26, 2008

Baxter Healthcare has issued an urgent U.S. recall of nine lots of the injectable blood thinner heparin after reports of adverse patient reactions.

The recall includes heparin sodium injection in 1,000 Units/mL, 10 mL and 30mL multi-dose vials with lot number. The lot numbers are 107054, 117085, 047056, 097081, 107024, 107064, 107066, 107074 and 107111

The company said it issued the recall as a precautionary measure while it investigates the cause of allergic-type reactions that include stomach pain or discomfort, nausea, vomiting, diarrhea, decreased or low blood pressure, chest pain, fast heart rate, dizziness, fainting, unresponsiveness and shortness of breath.

The 1,000 units/mL multi-dose vials are primarily used for hemodialysis and cardiac invasive procedures, the company said.

Copyright 2008 by United Press International

Explore further: Using feminist theory to understand male rape

add to favorites email to friend print save as pdf

Related Stories

Satellites tracking Central Pacific's Tropical Storm Ana

37 minutes ago

Tropical Storm Ana continued on a path to the Hawaiian Islands as NASA's Terra satellite passed overhead and gathered data on the storm. NOAA's GOES-West satellite data was compiled into a movie that showed ...

Wobbling of a Saturn moon hints at what lies beneath

56 minutes ago

Using instruments aboard the Cassini spacecraft to measure the wobbles of Mimas, the closest of Saturn's regular moons, a Cornell University astronomer publishing in Science, Oct. 17, has inferred that this small moon's icy su ...

Recommended for you

Using feminist theory to understand male rape

3 hours ago

Decades of feminist research have framed rape and sexual assault as a 'women's issue', leaving little room for the experiences of male victims. But a new study published in the Journal of Gender Studies suggests that feminist ...

Simulation-based training improves endoscopy execution

Oct 18, 2014

(HealthDay)—Simulation-based training (SBT) improves clinicians' performance of gastrointestinal endoscopy in both test settings and clinical practice, according to research published in the October issue ...

Data sharing in pharmaceutical industry shows progress

Oct 16, 2014

To enhance the transparency of clinical trials for new drugs, a number of pharmaceutical firms have begun sharing data with investigators outside their own companies. Brian L. Strom, chancellor of Rutgers Biomedical and Health ...

Swiss drug maker Roche posts flat 3Q sales

Oct 16, 2014

(AP)—Swiss drugmaker Roche Holding AG has reported "stable" or flat sales for the first nine months of 2013 but says the results show strong demand for its cancer drugs and emerging new products.

User comments : 0